Episode 154: ASCO GU 2022 MAGNITUDE trial of niraparib and abiraterone in metastatic CRPC

The Uromigos - A podcast by The Uromigos

Podcast artwork

Kim Chi describes the results of this randomised phase 3 study.

Visit the podcast's native language site